11 December 2019 : Clinical Research
The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma
DOI: 10.12659/MSM.917754
Med Sci Monit 2019; 25:9458-9470
HTML version available soon